Cerebrospinal Fluid and Blood Biomarkers of Neuroaxonal Damage in Multiple Sclerosis

被引：19

作者：

Dujmovic, Irena ^{[1
]}

机构：

[1] Clin Ctr Serbia, Neurol Clin, Dr Subotica 6,POB 12, Belgrade 11129 102, Serbia

来源：

MULTIPLE SCLEROSIS INTERNATIONAL | 2011年 / 2011卷

关键词：

D O I：

10.1155/2011/767083

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Following emerging evidence that neurodegenerative processes in multiple sclerosis (MS) are present from its early stages, an intensive scientific interest has been directed to biomarkers of neuro-axonal damage in body fluids of MS patients. Recent research has introduced new candidate biomarkers but also elucidated pathogenetic and clinical relevance of the well-known ones. This paper reviews the existing data on blood and cerebrospinal fluid biomarkers of neuroaxonal damage in MS and highlights their relation to clinical parameters, as well as their potential predictive value to estimate future disease course, disability, and treatment response. Strategies for future research in this field are suggested.

引用

页数：18

共 202 条

[1] Reduced NAA-Levels in the NAWM of Patients with MS Is a Feature of Progression. A Study with Quantitative Magnetic Resonance Spectroscopy at 3 Tesla [J].

Aboul-Enein, Fahmy ;

Krssak, Martin ;

Hoeftberger, Romana ;

Prayer, Daniela ;

Kristoferitsch, Wolfgang .

PLOS ONE, 2010, 5 (07)

[2] Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis [J].

Anderson, J. M. ;

Hampton, D. W. ;

Patani, R. ;

Pryce, G. ;

Crowther, R. A. ;

Reynolds, R. ;

Franklin, R. J. M. ;

Giovannoni, G. ;

Compston, D. A. S. ;

Baker, D. ;

Spillantini, M. G. ;

Chandran, S. .

BRAIN, 2008, 131 :1736-1748

[3] Abnormal tau phosphorylation in primary progressive multiple sclerosis [J].

Anderson, Jane Marian ;

Patani, Rickie ;

Reynolds, Richard ;

Nicholas, Richard ;

Compston, Alastair ;

Spillantini, Maria Grazia ;

Chandran, Siddharthan .

ACTA NEUROPATHOLOGICA, 2010, 119 (05) :591-600

[4] Evidence for abnormal tau phosphorylation in early aggressive multiple sclerosis [J].

Anderson, Jane Marian ;

Patani, Rickie ;

Reynolds, Richard ;

Nicholas, Richard ;

Compston, Alastair ;

Spillantini, Maria Grazia ;

Chandran, Siddharthan .

ACTA NEUROPATHOLOGICA, 2009, 117 (05) :583-589

[5] Aspects of β-amyloid as a biomarker for Alzheimer's disease [J].

Andreasson, Ulf ;

Portelius, Erik ;

Andersson, Malin E. ;

Blennow, Kaj ;

Zetterberg, Henrik .

BIOMARKERS IN MEDICINE, 2007, 1 (01) :59-78

[6] Tau-mediated neurodegeneration in Alzheimer's disease and related disorders [J].

Ballatore, Carlo ;

Lee, Virginia M. -Y. ;

Trojanowski, John Q. .

NATURE REVIEWS NEUROSCIENCE, 2007, 8 (09) :663-672

[7] Tau aggregation and toxicity in a cell culture model of tauopathy [J].

Bandyopadhyay, Bhaswati ;

Li, Guibin ;

Yin, Haishan ;

Kuret, Jeff .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (22) :16454-16464

[8] Imaging outcomes for neuroprotection and repair in multiple sclerosis trials [J].

Barkhof, Frederik ;

Calabresi, Peter A. ;

Miller, David H. ;

Reingold, Stephen C. .

NATURE REVIEWS NEUROLOGY, 2009, 5 (05) :256-266

[9] Antibodies against light neurofilaments in multiple sclerosis patients [J].

Bartos, A. ;

Fialova, L. ;

Soukupova, J. ;

Kukal, J. ;

Malbohan, I. ;

Pitha, J. .

ACTA NEUROLOGICA SCANDINAVICA, 2007, 116 (02) :100-107

[10] Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis [J].

Bartos, Ales ;

Fialova, Lenka ;

Soukupova, Jirina ;

Kukal, Jaromir ;

Malbohan, Ivan ;

Pit'ha, Jiri .

JOURNAL OF NEUROLOGY, 2007, 254 (01) :20-25

← 1 2 3 4 5 6 7 8 9 10 →